# Trade Mark Journal No.2025/027 4 July 2025

## WO0000001849083 (5)

Office of origin: United States of America

Date of International Registration:12 March 2025
Date of designation in the UK: 12 March 2025

International priority date claimed: 13 September 2024 (United States of America) (98749939)

Class 5
  Pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders.

Immunome, Inc.

Representative: Lori J. Shyavitz, Esq. McCarter & English, LLP, 265 Franklin Street, Boston MA 02110-3113, UNITED STATES OF AMERICA